NCT03914742 2025-01-14BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 MutationsSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Completed67 enrolled 18 charts